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Summary 
A  self-peptide containing amino acid residues 46-61  (NRGDQSTDYGIFQINSR.)  of mouse 
lysozyme (ML) (p46-61, which binds strongly to the A k molecule but does not bind to the E k 
molecule), can induce a strong proliferative T  cell response in CBA/J mice (A  k, E k) but no re- 
sponse at all in B10.A(4R.) mice (A  k, E~  However, two truncated forms ofp46-61, p48-61, or 
p46-59, are immunogenic in both B10.A(4P,) and CBA/J mice. The critical residues within 
p46-61  reside between amino acid positions 51  and 59.  T  cells  of B10.A(41L)  mice primed 
with the truncated peptides in vivo cannot be restimulated by p46-61  in vitro. This suggests 
that T  cell receptor (TCP,) contact (epitopic) residue(s)  flanking the minimal 51-59 determi- 
nant within p46-61  hinder the interaction of the p46-61/A  k complex with  the  appropriate 
TCI<(s),  thereby causing a lack of proliferative T  cell  response in this mouse strain.  Unlike 
BI0.A(4R)  mice,  [B10.A(4R)￿  mice responded vigorously to p46-61,  suggesting 
that thymic APC of B10.A(4R) mice do not present a selfligand to T  cells resulting in a p46- 
61--specific  hole in the T  cell repertoire in B10.A(4R) or the F1 mice. Moreover, APC from 
B10.A(4R)  mice are capable of efficiently presenting p46-61  to peptide-specific T  cell lines 
from CBA/J mice. The proliferative unresponsiveness of  B10.A(4R.) mice to p46-61 is not due 
to non-major histocompatibility complex genes because B10.A mice (A  k, E k) respond well to 
p46-61. Interestingly, B10.A(4P,) mice can raise a good proliferative response to p46-61(R61A) 
(in which the arginine residue at position 61  (R61) ofp46-61 had been substituted by an ala- 
nine residue) or equally well to p46-61  (P,61L/F/N/K), indicating that R61  was indeed re- 
sponsible for hindering the interaction ofp46-61 with the appropriate TCR.. Finally, chimeric 
mice  [B10.A(4PQ-+B10.A]  responded vigorously to p46-61,  suggesting that thymic antigen 
presentation environment of the B10.A mouse was critical for development of a p46-61-reac- 
tive T cell repertoire. Thus, we provide experimental demonstration of a novel mechanism for 
unresponsiveness to a self peptide, p46-61, in the B10.A(4R.) mouse owing to hindrance: in 
this system it is the interaction between the available  TCR. and the Ak/p46-61 complex, which 
is hindered by epitopic residue(s)  within p46-61. We argue that besides possessing  T  cells that 
are hindered by 1L61 ofp46-61, CBA/J and B10.A mice have developed an additional subset 
ofT cells bearing TCRs which are not hinderable by P,61, presumably through positive selec- 
tion with peptides derived from class II E k, or class I Dk/D  a molecules. These results  have im- 
portant implications in self tolerance, shaping of the T  cell repertoire, and in defining suscepti- 
bility to autoimmunity. 
T 
olerance to determinants within a self-protein occurs 
through several mechanisms.  During development of 
the  T  cell repertoire in  the  thymus,  the  thymocytes that 
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recognize self-peptide/self-MHC complexes with high af- 
finity/avidity undergo  clonal deletion owing to apoptosis 
during the process of negative selection (1-4). In addition, 
thymic T  cell tolerance (central tolerance) can also  be in- 
duced by nondeletional mechanisms  (3, 5).  Thymic toler- 
ance can only be induced to those self determinants that are 
processed and presented most efficiently by the APC in the 
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nisms  are needed to control the  activity of T  cells  poten- 
tially reactive to antigens that are only expressed in the pe- 
riphery  (peripheral  tolerance).  Several  mechanisms  have 
been  proposed  for  induction  of peripheral  tolerance:  (a) 
mature T  cells  that recognize a self determinant  on a non- 
professional APC in the  absence  of a  costimulatory signal 
are rendered anergic  (6-8), whereas T  cells  that are stimu- 
lated by a high concentration of a peripheral  antigen pre- 
sented by a professional APC can undergo deletion by apop- 
tosis (peripheral deletion)  (9-11).  (b) The activity of T  cells 
that respond to a self-antigen can be effectively modulated 
through regulatory or suppressor T  cells and cytokines (12- 
15).  (c)  Downregulation  of the  TCP,.  on  self-reactive  T 
cells  (16)  or (d) altered/impaired  TCR  signaling leading to 
clonal inactivation,  provide  additional  mechanisms for in- 
duction of self-tolerance  (17).  (e)  It has recently been sug- 
gested in a transgenic model of spontaneous autoimmunity 
that peripheral  tolerance was a diversion of the differentia- 
tion  of autoreactive  T  cells  towards  Thl  or Th2  effector 
phenotypes (18). 0~ In another case oftransgenic mice with 
autoreactive TCI<, self-tolerance was attributed to a defec- 
tive  costimulatory process in transgenic  T  cells  (clonal in- 
sufficiency) (19). 
In this  paper,  we report  a  novel mechanism to  explain 
the lack of response to a self-peptide, p46-61(NRGDQST- 
DYGIFQINSR.),  of mouse  lysozyme  (ML) l  (20,  21)  in 
B10.A(4R)  mice,  attributable  to hindrance  by TCP,  con- 
tact (epitopic) residues in the interaction between the avail- 
able  TCR  and  the  Ak/p46-61  complex.  (ML p46-61  had 
been referred to as p46-62  in previous studies  [22-24].  In 
our earlier study (21)  as here, we have numbered the extra 
glycine residue at position 48 of ML as 47a for easier com- 
parison  with  the  sequence  of  hen  eggwhite  lysozyme 
[HEL]). Our results suggest that T  cells reactive to determi- 
nant(s) within p46-61 exist in B10.A(4P,.) mice but these T 
cells  can be activated only by peptides lacking the NH2- or 
COOH-terminal  flanking  residue(s)  but  not  by  p46-61, 
and  that  the  above-mentioned  hindrance  can  be  relieved 
by alanine  (or L/F/N/K)  substitution of a putative hinder- 
ing residue,  COOH-terminal  arginine  (R61),  within p46- 
61.  In  this  regard,  we  suggest  that  other  Ak-displaying 
mouse strains,  CBA/J and B10.A, can circumvent this hin- 
drance  because  of an  additional  subset  of T  cells  that  are 
unhindered by R61 in p46-61; these T  cells were presum- 
ably  positively  selected  by  that  region  of H-2  k  MHC, 
which  has  been  deleted  in  B10.A(4R)  mice  during  the 
chromosomal recombination event.  The results of our ex- 
periments using bone marrow chimeras support the above- 
mentioned hypothesis. 
Materials  and Methods 
Mice.  B10.A(4R)  (Ak,E~  CBA/J  (Ak,Ek), and  B10.A  (A  k, 
E  k) mice were purchased from The Jackson Laboratory (Bar Har- 
1Abbreviations used in this paper: APL, altered peptide ligand; HEL, hen 
eggwhite lysozyme;  ML, mouse  lysozyme;  PPD, purified protein derivative. 
bor, ME) and bred in our aroma/facility.  [B10.A(41<)X CBA/J]F1 
mice were also bred in the same facility. Female  mice, 6-16 wk 
of age, were used in the experiments. 
Peptide Synthesis and Purification.  Mouse  lysozyme (ML) (20, 
21)  peptides  were  obtained  from the  following sources:  (a)  A 
peptide  containing amino  acid  residues  48-61  of ML  (p48-61) 
(DQSTDYGIFQINSR) was synthesized  in our laboratory using 
the  rapid  simultaneous  solid-phase  multiple  peptide  synthesis 
methodology, the so-called  "teabag" method, which is based on 
Merrifield's  original  solid-phase  procedure (25). The peptide was 
generated on a tert-butyloxycarbonyl-amino acid-phenylacetami- 
domethyl (Pam) resin and its amino acid composition analyzed as 
previously described  (21,  26).  (b)  Overlapping  15-mer peptides 
spanning the  sequence  of ML from amino acid residues  40-68 
(TRATNYNP,.GDQSTDYGIFQINSRYWCNDGK were  ob- 
tained from Chiron Mimotopes (Clayton,  Australia). The peptides 
were synthesized using the "multi-pin" peptide synthesis technique 
(27). The terminal  amino group of each peptide was acetylated, 
whereas  the  carboxy-terminal  lysine-proline  residues  formed 
diketopiperazine.  (c)  ML  peptides  48--61 (p48-61)  and  46-61 
(p46-61)  (NR.GDQSTDYGIFQINSR) were  synthesized  by Dr. 
Craig Miles, Macromolecular Resources, Colorado State Univer- 
sity,  Fort  Collins,  CO.  Manual  or automated peptide  synthesis 
was  performed  using  tert-butyloxycarbonyl  amino  acids  as  de- 
scribed elsewhere  (21). (at) ML peptides,  p40-53, p42-55, p44-57, 
p46-59 (NR.GDQSTDYGIFQIN), p46-61, p50-64, p52-66, p46- 
61(R.61A) (a peptide having the same sequence as that ofp46-61, 
except that at position 61 there is an alanine in place of the argin- 
ine  residue),  p46-6(R.61L),  p46-61(R61F),  p46-6(R.61N),  p46- 
61(R61K), p46-61 (N46A), p46-61 (R47A), p46-61(R.47L),  p46- 
61(N59A),  and  p46-61(S60A)  were  synthesized  in  the  UCLA 
Peptide Core Laboratory directed by Dr. Joseph 1<. Reeve, Jr., us- 
ing a multiple  peptide synthesizer  (396; Advanced Chem Tech, 
Louisville, KY). The identity and purity of the above-mentioned 
peptides  were determined by fast atom bombardment mass spec- 
trometry. (e) Additionally, a sample ofp46-61 was kindly provided 
by Dr. Luciano Adorini, Roche Milano Ricerche, Milano, Italy. 
Lymph Node Proliferation Assay.  Mice  were  immunized  with 
7-14 nmol (or higher concentrations) per mouse of an ML pep- 
tide in PBS, in 1 : 1 (vol/vol) emulsion with CFA (Difco Labora- 
tories,  Detroit,  M[),  in a hind footpad.  After 9  d,  the  draining 
lymph nodes were removed, cell suspensions  washed twice with 
HBSS  (GIBCO  BRL,  Life  Technologies,  Inc.,  Grand  Island, 
NY), and then cultured in a flat-bottom 96-well plate  at a con- 
centration  of 5  X  105  cells/well  in  HL-1  serum-free  medium 
(Ventrex  Laboratories,  Inc., Portland, ME)  supplemented with 2 
mM  t-glutamine,  100  U/ml  penicillin  G  sodium,  100  btg/ml 
streptomycin sulfate,  and different  concentrations (1.75-14  txM 
or higher, final concentration) of the antigen.  For the pin pep- 
tides, one or two wells were tested per peptide.  Tuberculin puri- 
fied protein  derivative  (PPD)  (Parke-Davis,  Morris  Plains,  NJ) 
was used at a final concentration of 4 p,g/well as a positive  con- 
trol. The cells were incubated with 1 I*Ci/well of [3H]thymidine 
(International  Chemical  and  Nuclear,  Irvine,  CA)  for the  last 
18 h of a 5-d culture. Then, the cells were harvested  using a Mi- 
cro Cell Harvester (Skatron  Instruments,  Inc., Sterling,  VA), and 
the incorporation of radioactivity was assayed by liquid scintilla- 
tion  counting,  using the  1205  Betaplate  counter  (LKB  Instru- 
ments,  Inc.,  Gaithersburg,  MD).  The  results  were  expressed  as 
mean counts per minute  of duplicate  or triplicate  cultures.  For 
presentation  of data,  background  (LNC  cultured  in  medium 
without antigen)  values  of cpm were  subtracted  from the  cpm 
obtained with LNC plus antigen.  The final results from a group 
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mean A cpm +  SEM.  The results obtained with a peptide syn- 
thesized by the teabag method were confirmed with pin peptides 
as well as peptides obtained from other sources, and vice versa. 
For some repeat experiments, HL-1 medium supplemented with 
1%  (vol/vol) heat-inactivated FCS  (Gemini Bio-Products, Inc., 
Calabasas, CA) or X-Vivo 10 serum-free medium (Bio-Whittaker, 
Walkersville, MD) with or without 2% FCS was used in place of 
HL-1 serum-free medium. The results of these experiments were 
comparable to  those of the  earlier experiments using the  same 
peptides in which HL-1 medium or X-vivo 10 medium without 
FCS supplementation was used. 
Generation and Long-Term Maintenance of T Cell Lines.  CBA/J 
mice were immunized with 7 nmol ofp46-61 emulsified in CFA 
(1 : 1,  vol/vol) in a hind footpad. After 9 d, the draining lymph 
nodes were removed, single cell suspensions prepared, and washed 
twice with HBSS. The cells were bulk cultured in a 25-cm  2 tissue 
culture flask (Coming Inc., Coming, NY) in 10 ml of Dulbecco's 
modification of  Eagle's medium (DMEM) (Mediatech Inc., Hem- 
don, VA) supplemented with 2 mM L-glutamine, 100 U/ml pen- 
icillin G  sodium,  100  I~g/ml streptomycin sulfate,  5  X  10 -5 M 
2-ME (Sigma Chemical Co., St. Louis, MO), and 10% (vol/vol) 
heat-inactivated FCS in the presence ofp46-61. After 2 wk, 6 ~1 
of recombinant human  IL-2  (Proleukin,  1 mg/rnl stock; Cetus 
Corp.,  Emeryville, CA)  was added per flask  and cells were al- 
lowed to grow for another 2 wk. Thereafter, cells were restimu- 
lated with irradiated (3,000 rads) syngeneic APC and p46-61. In 
this way, cells were subjected to several alternating cycles of stim- 
ulation with antigen/IL-2 at intervals of 2-3 wk until the requi- 
site number of cells were obtained for testing. The antigen speci- 
ficity of these T  cell lines was tested using a proliferation assay as 
described below. 
Proliferation Assay Using T Cell Lines.  T cell lines derived from 
CBA/J mice, 5  X  104 or 1 X  10  s cells/well, were cultured with 
3-5 X  105 cells/well of irradiated (3,000  rads) splenic APCs from 
CBA/J or B10.A(4R.) mice in HL-1  serum-free medium as de- 
scribed above, using different concentrations of antigen.  There 
were three sets of controls in the assay: (a) APC alone in medium 
without antigen, (b) APC plus T  cells in medium without anti- 
gen, and (c) T  cells alone in medium with antigen but no APC. 
Proliferation of T  cells was  measured by addition of 1 ~Ci  of 
[3H]thymidine/well for the last 18 h ofa 3-d culture. Incorpora- 
tion of radioactivity  was assayed by liquid scintillation counting as 
described above. The results were expressed as A cpm. 
MHC Binding Assays.  A k molecules were  purified from de- 
tergent-solubilized CH27  (28) B lymphoma membrane prepara- 
tions  using  a  10-2-16  mAb  immunoaffinity  column.  Binding 
assays were performed using a modification of the procedure pre- 
viously described (29). In brief, purified A k (50 nM) was incubated 
with 1 ixM biotin peptide and various concentrations of compet- 
itor peptides in 30-btl samples containing 0.2% NP-40 and 20 mM 
citrate/phosphate buffer, pH 5, for 18 h at 37~  Biotin peptide/ 
MHC complexes were captured on assay plates coated with 10-2-16 
mAb. After washing, excess europium streptavidin was added and 
fluorescence was measured at 612  nm as described (29).  Results, 
representing mean  biotin peptide/class II  complexes from  du- 
plicate samples,  are expressed as fluorescence counts per second 
(cps X  10-3). 
Radiation-induced Bone Marrow Chimeras.  Chimeric mice were 
prepared essentially according to the method described elsewhere 
(30,  31)  with a few minor modifications. Briefly, 12-18-wk-old 
B10.A mice were irradiated with 950 rads using a Co  60 source (at 
the  Laboratory of Structural Biology and Molecular Medicine, 
UCLA). Within 24 h of irradiation, mice were given 1-2 X  107 
T  cell-depleted bone marrow  cells i.v., derived from age- and 
sex-matched B10.A(4K) mice. The bone marrow cells that were 
treated with monoclonal anti-Thy 1.2 antibody, Jlj. 10 (American 
Type Culture Collection [ATCC], tLockville, MD)  and guinea 
pig complement (GIBCO BRL, Life Technologies, Inc.) in vitro 
did not reveal any proliferative responsiveness to Con A. Recipi- 
ents were given neomycin sulphate (GIBCO BRL, Life Technol- 
ogies, Inc.) (2 g/liter) in their drinking water beginning 10 d before 
irradiation and continuing throughout the period of experiment. 
Splenic cells  of chimeric mice were stained with  two  different 
mAbs separately, 14-4-4S (ATCC)  (reactive with the mouse E k 
molecule) and KH95 (specific for the mouse D b molecule) (Pharm- 
ingen, San Diego, CA). Isotype-matched m_Abs were used as con- 
trols and  FITC-conjugated appropriate second antibodies were 
used.  Stained cells were  fixed with  1% formaldehyde and ana- 
lyzed by a cytofluorograph (Becton Dickinson and Co., Moun- 
tain View, CA). Splenic cells of our chimeras were negative for 
E k but positive for D b, and the staining profile of cells of chimeric 
mice was similar to that of naive B10.A(4R) mice (data not shown). 
Chimeric mice were immunized with ML p46-61/CFA for LN 
proliferation assay (see above) after 10-12 wk ofreconstitution. 
Results 
Response of BIO.A(4R)  and  CBA/J  Mice  to  p46-61  of 
Mouse Lysozyme.  Response  to  p46-61  of ML  was  tested 
in B10.A(4R)  (Ak,E  ~  and CBA/J  (Ak,E  k) mice. This pep- 
tide binds strongly to  the A k molecule but  not  to  the  E k 
molecule  (22-24,  32).  Mice  were  immunized  in  a  hind 
footpad with p46-61  emulsified in CFA, and after 9  d, the 
draining LNC were tested for proliferative response to the 
same peptide in vitro. The  results are presented in Fig.  1. 
B10.A(4R)  mice did not give any proliferative response to 
p46-61,  whereas CBA/J mice responded vigorously to the 
same peptide. B10.A(4K) mice did not respond even when 
very  high  concentrations  (30-50  nmol)  of p46-61  were 
used for immunization (data not shown). 
T Cells  from  CBA/J Mice Primed with p46-6I  In Vivo Also 
Respond to  Certain Overlapping Peptides Spanning the Region 
40--68 of ML In Vitro.  CBA/J mice were immunized with 
p46-61/CFA,  and  after 9  d  the  response  of the  draining 
LNC  was  recalled in vitro  using different ML peptides at 
three concentrations each: 0.7,  7,  and  14  btM.  The results 
of a representative experiment using 7  ~M of each peptide 
are given in Fig. 2. These results demonstrate that the criti- 
cal amino acid residues within the ML determinant that is 
comparable to HEL p46-61  (33)  is very different: the ML 
core determinant is 51-59, whereas the HEL core determi- 
nant is 52-61. 
Response of CBA/J and BIO.A(4R) Mice to  the  Truncated 
MLPeptides, p48-6I andp46-59.  To  determine  the  im- 
portance of amino acid residues at the NH 2 or COOH  ter- 
minus of the longer peptide, ML p46-61, in binding to the 
MHC  or  in  interaction  with  the  TCR,  peptides lacking 
residues 46, 47, and 47a (p48-61) or 60 and 61  (p46-59) of 
p46-61  were  tested  for  their  immunogenicity  in  CBA/J 
and B10.A(4R)  mice using an LN proliferation assay. It is 
clear from  the  results  shown  in  Fig.  3  that,  like p46-61, 
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Figure  1.  CBA/J (ll--m) but not B10.A(4R) ([S]-q~) mice respond to 
ML peptide 46-61 (NRGDQSTDYGIFQINSR).  Mice were immunized 
in a hind footpad with p46-61 of ML emulsified in CFA, and after 9 d, 
the response of the draining LNC was tested using a T cell proliferation 
assay. The results from a group of six animals of each mouse strain were 
expressed as mean A cpm •  SEM. Similar  results  were obtained on repeat 
experiments. Identical patterns of proliferative responses were observed 
with three different preparations of p46-61 (see Materials and Methods). 
PPD responses  of CBA/J and B10.A(4R) mice were comparable in mag- 
nitude, and ranged from 92,030 to 246,290 cpm. 
p48-61  and p46-59  each induced a  strong proliferative T 
cell response in CBA/J mice. Thus, it is evident that all three 
peptides can bind optimally to  the A k molecule,  and  that 
immunogenicity of the  determinant(s)  within  p46-61  was 
not affected by the absence of certain amino acid residues 
within p46-61. 
Surprisingly, B10.A(4R) mice, which did not respond at 
all to p46-61, produced potent proliferative T  cell responses 
to p48-61 or p46-59 (Fig. 3). These results demonstrate that 
T  cells potentially reactive to the core determinant within 
p46-61  exist in B10.A(4R) mice. However, T  cells primed 
with  the  above  truncated  peptides  in  vivo  could  not  be 
stimulated in vitro with p46-61  (data not shown), suggest- 
ing that the interaction of these T  cells with p46-61  is not 
efficient enough to induce a proliferative T  cell response to 
this peptide. As discussed below,  we  attribute this lack of 
response to p46-61  to epitopic hindrance. 
Amino Acid  Residues at  the NH  2 or COOH  Terminus of 
ML p46-61,  Including Arginine Residues (R  47 /R 61) Are Not 
Critical  for Binding to A k.  To define further the function of 
amino acid residues at either terminus ofp46-61, we tested 
the A k binding of variants ofp46-61  prepared by substitut- 
ing one amino acid at a time with an alanine residue. The 
following peptides were tested in the assay: p46-61 (N46A), 
p46-61(R47A),  p46-61(N59A),  p46-61(S60A),  and  p46- 
61(R61A). The results given in Fig. 4 show that A k binding 
of each of the above five peptides was comparable to that 
of the native peptide, ML p46-61.  Overall, the binding af- 
finities of variant ML peptides and ML p46-61 were within 
one log of the positive control, HEL p46-61. These results 
demonstrate that amino acid residues at the NH 2 or COOH 
terminus of ML p46-61,  including terminal arginines, R47 
or R61  are not critical for the binding of this peptide to the 
A k molecule,  Therefore,  in  the  AVp46-61  complex,  the 
above-mentioned residues are most likely projecting out- 
ward toward the TCR  and thus could hinder the interac- 
tion between the AVp46-61  complex and the TCR. 
[BIO.A(4R)XCBA/J]F1  Mice Raise  Vigorous Proliferative 
Responses top46-61.  To  address  further  the  mechanism 
underlying the unresponsiveness of B10.A(4R) mice to p46- 
61,  we  studied  the  response  of  [B10.A(4R)XCBA/J]F1 
mice to p46-61. We reasoned that if the lack of response of 
B10.A(4R) mice to p46-61 were due to a hole in the T  cell 
repertoire caused by expression of a  self-peptide/A  k com- 
plex in the thymus during development of the T  cell reper- 
toire, then the same ligand should also lead to a similar hole 
in the T  cell repertoire in the case of [B10.A(4R)X CBA/J]F 1 
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Figure  2.  The core of the determinant within ML 
p46-61 in CBA/J mouse is 51-59, as peptides 46-59 
through 51-65 are positive. Mice were primed with 
p46-61 and 9 d later the draining LNC were exam- 
ined for response to an almost complete set of over- 
lapping 15-mer peptides spanning the region 40-68 
of  ML  (TKATNYNRGDQSTDYGIFQINSRY- 
WCNDGK; G following R47 has been numbered as 
47a [21]) using 7 I.LM of each peptide. The results of 
a representative experiment expressed as A cpm are 
shown in the figure. Similar results were obtained on 
repeat experiments. Medium alone (cells cultured in 
medium without antigen) gave 1,498 cpm. 
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Figure 3.  Both  CBA/J and B10.A(4R) mice respond to ML peptides 
48-61 (DQSTDYGIFQINSR) (CBA/J [O'-O], B10.A(4R) [O-0]) and 
46-59 (NRGDQSTDYGIFQIN) (CBA/J [[~-C]], B10.A(4R) [i-i]). 
Mice were immunized in a hind footpad with one of the ML peptides 
emulsified in CFA, and 9 d later, the proliferative response of draining 
LNC was measured￿9  For each mouse, the peptide that was used for im- 
munization  was also used for the in vitro recall response. The results from 
four animals  of each mouse strain immunized  with p48-61 or p46-59 are 
shown as mean  A cpm -+ SEM. 
mice rendering them completely unresponsive to p46-61. 
As shown in Fig. 5, F1 mice raised a potent proliferative re- 
sponse to p46-61, and the level of response was comparable 
to that of CBA/J mice. 
APC from BIO.A(4R) Mice Can Present  p46-6I  to  T  Cell 
Lines  from CBA/JMice.  We  tested  the  ability of splenic 
APCs of B10.A(4R) mice to stimulate T  cell lines specific 
for p46-61  derived from  CBA/J  mice  (see  Materials and 
Methods), using a proliferation assay.  The results presented 
in Fig. 6  demonstrate that B10.A(4R) APC can efficiently 
present p46-61 to the peptide-specific T  cells, and that the 
level of proliferation using B10.A(4R)  and  CBA/J  APC 
was  comparable. Thus, the lack of response to p46-61  in 
B10.A(4R) mice is not due to a defect in antigen presenta- 
tion by APC of this mouse strain. Obviously then, the de- 
fect must lie at the level of the T  cell. 
Ala (or Leu/Phe/Asn/Lys) Substitution of Arg-61 or Arg-47 
Renders p46-61 Immunogenic in BIO.A(4R) Mice.  From the 
above results, we predicted that epitopic residues within p46- 
61, most likely the bulky arginine residue(s) at position 61 
(R61) and/or 47  (R47), were responsible for hindrance in 
the  TCR-p46-61/A  k  complex  interaction in BI0.A(4R) 
mice.  Therefore,  we  examined  the  immunogenicity of 
p46-61(R61A)  (in which R61  was  substituted by an ala- 
nine residue) as well as p46-610K61L), p46-61 (R61F), p46- 
Figure 4.  Relative  binding affinities  of ML p46-61 variants  for A  k. Pu- 
rified A  k (50 nM) was incubated with 1 ~M biotin-HEL p46-61 in the 
presence of competitor peptides at the indicated concentrations  at pH 5 
for 18 h at 37~  Bound biotin peptide was quantified  using a europium 
fluorescence immunoassay  as described in Materials and Methods. The 
fluorescence signal  in the absence of competitor was 275 cps X 10 -3. Re- 
sults are representative  of two experiments. 
61(R61N), p46-6(R61K) and p46-61(R47L) in B10.A(4R) 
mice.  These  results  given  in  Figs.  7  and  8  show  that 
B10.A(4R)  mice can raise  strong proliferative responses to 
p46-61(R61A) (Fig. 7) and to each of the other R61/R47- 
substituted  peptides  tested,  but  not  to  native  p46-61 
[=p46-61(R61)]  (Fig.  8).  Interestingly, B10.A(4R)  mice 
immunized with p46-61(R61F) (A) gave the best recall re- 
sponse with p46-61(R61L) and vice versa (B). However, in 
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Figure 5.  [B10.A(4R)XCBA/J]F1  mice raise vigorous proliferative  re- 
sponses to p46-61. Mice were immunized with p46-61/CFA in a hind 
footpad and 9 d later, the draining  LNC were tested using a T cell prolif- 
eration assay￿9 The results from a group of four mice were expressed as 
mean A cpm -+ SEM. Similar  responses were obtained on repeat experi- 
ments. 
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Figure 6.  APC from B10.A(4R) 
mice can efficiently  present p46-61 
to T cell lines derived from CBA/J 
mice. Two p46-61--specific  T cell 
lines,  CBAML61.1  (A)  and 
CBAML61.2  (B), both  derived 
from  CBA/J  mice  (see Materials 
and Methods) were used in a pro- 
liferation  assay using irradiated 
(3,000  rads) APC  from  CBA/J 
(O-"O),  or  B10.A(4R)  (~-O) 
mice in  the  presence of different 
concentrations  of  p46-6t.  The 
level of cpm obtained with T cells 
cultured with p46-61 but without 
added APC  was  not higher  than 
that of T cells plus APC cultured 
in  medium without  antigen (data 
not shown). The results of a repre- 
sentative experiment are given as 
A  cpm. Similar results were  ob- 
tained in repeat experiments. 
both instances, there was no appreciable recall response with 
p46-61(R61N).  In summary, the above results clearly dem- 
onstrate  that  R61  or R47  was  indeed responsible for the 
above-mentioned hindrance. 
Response of Bl O.A Mice to ML p46-61,  To determine the 
role of B10.A background genes in the unresponsiveness of 
B10.A(4R)  (A  k, E ~  mice to p46-61, we studied the immu- 
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28 
nogenicity ofp46-61  in B10.A mice (A  k, Ek). Surprisingly, 
p46-61  induced  a  strong  proliferative response  in  B10.A 
mice (Fig. 9). Thus,  the lack of response to this peptide in 
B10.A(4R)  mice  in  contrast  to  responsiveness  of CBA/J 
mice  to  the  same  peptide  cannot  be  attributed  to  differ- 
ences in non-MHC  genes of these two strains. 
Radiation-induced  Chimeric  [BIO.A(4R)--~BIO.A]  Mice 
Respond to p46-61.  To test our hypothesis that the subset 
of T  cells unhindered by R61  within p46-61  is positively 
selected only in B10.A and CBA/J  mice but is lacking in 
B10.A(4R)  mice,  we  prepared  radiation-induced  bone 
marrow chimeras. In these chimeric mice, irradiated B10.A 
mice  were  reconstituted with  T  cell-depleted bone  mar- 
row  cells from B10.A(4R)  mice  (see Materials and Meth- 
ods for details). 10-12  wk after irradiation, chimeric mice 
were immunized with p46-61/CFA in a hind footpad. Af- 
ter 9  d, the draining LNC were tested for proliferative re- 
sponses to p46-61. The results given in Fig. 10 demonstrate 
that  chimeric  mice  could  raise  vigorous  proliferative re- 
sponses to p46-61  (whereas B10.A(4R)  mice did not  [Fig. 
1]). In the same series of experiments, unmanipulated B10.A 
mice immunized with p46-61/CFA raised good prolifera- 
tive responses to p46-61, and the magnitude of their prolif- 
erative responses was comparable to that of the chimeric mice 
(data not shown). Thus, the T  cell repertoire of B10.A(4R) 
mice  lacked T  cells that  could respond to p46-61.  How- 
ever,  under  the  thymic  microenvironment  provided  by 
B10.A mice in chimeric mice, bone marrow T  cell progen- 
itors from B10.A(4R)  mice whose TCR  could potentially 
accommodate p46-61/A  k complex could be positively se- 
lected. 
Figure 7.  p46-61(R61A) is irmnunogenic in B10.A(4R) mice. Mice 
were immunized with a peptide, p46-61(R61A) emulsified in CFA, hav- 
ing an alanine residue in place of the arginine residue at position 61  of 
p46-61. The proliferative response of draining LNC was measured after 
9 d. The results from four mice are given as mean A cpm +  SEM. Like 
B 10.A(4R) mice CBA/J mice also gave a significant  proliferative response 
to p46-61(R61A), and the level of response in the two mouse strains  was 
comparable (data not shown). 
Discussion 
In previous studies, p46-61  of ML has been successfully 
used in B10.A(4R)  and C3H.HeJ  (A  k, E k) mice to inhibit 
in vitro T  cell responses to Ak-restricted (but not Ek-restticted) 
determinants within foreign antigens through MHC  block- 
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Figure 8.  Responses of B10.A(4P~) mice to variants of 
p46-61 having the arginine residue at positions 61  or 47 
substituted with  one  of the  following: Phe(F), Leu(L), 
Asn(N), or Lys(K). Mice were immunized with one of the 
variants ofp46-61  (A) R61F;  (B) R61L;  (C) R61N;  (D) 
P,.61K; (E) R47L; and (F) R47A,  and the prohferative T 
cell response in each case was recalled in vitro with differ- 
ent variants ofp46-61 or with native p46-61. The results 
were expressed as stimulation indices (SI = cpm with anti- 
gen/cpm without antigen). The results of a representative 
experiment are shown in the figure. Similar results were 
obtained in repeat experiments. 
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Figure 9.  B10.A  mice can respond to p46-61. Mice were immunized 
with p46-61/CFA in a hind footpad, and 9 d later, proliferative responses 
of  draining LNC were tested. The results from a group of  four animals  are 
presented as mean A cpm + SEM. 
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ade  (22-24).  Furthermore,  it was  shown  that ML p46-61 
was  nonimmunogenic  in  the  above  strains  of mice  (22, 
23, 34).  Interestingly,  our  results  demonstrate  that  other 
Ak-displaying mouse  strains,  CBA/J  and B10.A,  have  the 
ability to respond to p46-61.  Since all the above strains of 
mice presumably share an identical A k molecule, the unre- 
sponsiveness of B10.A(4R) mice to p46-61  could be attrib- 
utable  to:  (a)  a  complete  hole  in  the  T  cell  repertoire, 
whereby  T  cells bearing  TCR  potentially capable  of re- 
sponding to all determinant(s)  within p46-61  were  absent 
from  the  T  cell repertoire,  (b)  a  defect in presentation  of 
p46-61  by APC of B10.A(4R) but not CBA/J mice attrib- 
utable to differences in non-MHC  genes, or (c) the existence 
of T  cells potentially reactive to determinant(s) within p46- 
61,  but  only  activatable by  p46-59  or  p48-61;  however, 
owing to hindrance,  their interaction with the p46-61/A  k 
complexes on B10.A(4R) APC could not generate a T  cell 
response. 
Our results from two sets of experiments do not support 
the possibility of a complete hole in the T  cell repertoire of 
B10.A(4R)  mice  for  T  cells potentially reactive with  the 
determinant(s)  within  p46-61:  (a)  p48-61  and  p46-59, 
lacking amino acid residues at either the NH 2 or COOH 
terminus ofp46-61,  respectively, can generate valid T  cell 
responses, indicating that T  cells reactive against the immu- 
nogenic determinant(s) within p46-61 with a core of 51-59, 
do  exist in  this mouse  strain.  However,  these  T  cells can 
only be recruited by p48-61  or p46-59 but not by p46-61, 
which has extensions at either end. As discussed below, we 
attribute this ineflacient interaction to hindrance caused by 
epitopic residue(s) within p46-61,  most likely at the bulky 
arginine residues, P,.47 and R61.  (b) [B10.A(4R.)X CBA/J]F1 
mice  raised  a  potent  proliferative response  to  p46-61.  If 30 
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there were a p46-61-specific hole in the T  cell repertoire 
of B10.A(4R)  mice caused by a self-peptide/A  k complex, 
then the same hgand should also have caused a defect in the 
T  cell repertoire of the F1 mice. On the contrary, if the re- 
sponsiveness  to  p46-61  were  determined  by  a  particular 
subset oft  cells which are unhindered by R61 as described 
below in the case of CBA/J and B10.A mice, then the defi- 
ciency of these  T  cells  in B10.A(4R)  mice should be  re- 
lieved by the  CBA/J parent.  Unresponsiveness  to an anti- 
gen  owing to  a  hole  in  the  T  cell  repertoire  of F1  mice 
caused by tolerance  induced by a  self ligand  expressed  in 
one  of the parents  has been previously described  in other 
systems (35, 36), and in both these cases the unresponsive- 
ness  was  dominant  in  nature.  Thus,  in  this  study  the  re- 
sponsiveness of the F1  mice to p46-61  is attributable  to T 
cell clones owing their existence  to CBA/J parental  genes 
in the F1. 
The unresponsiveness of B10.A(4R) mice to p46-61, in 
contrast  to  responsiveness  of CBA/J  mice  to  the  same 
peptide,  cannot be  attributed  to  defective  presentation  of 
antigen to T  cells by B10.A(4R) APC due to differences in 
non-MHC  genes  of the  two  mouse  strains.  Two  sets  of 
data  support  the  above  conclusion.  First,  APC from both 
B10.A(4R)  and  CBA/J  mice could efficiently present  the 
immunogenic  determinant  within p46-61  to p46-61-spe- 
cific T  cells  raised in CBA/J mice.  Furthermore,  at a given 
concentration of p46-61, the level of proliferation induced 
by APCs from the above two mouse strains was compara- 
ble. Second, B10.A mice having the same A k molecule and 
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Figure  10.  Radiation-induced bone marrow chimeric 
[B10.A(4R)--)B10.A] mice respond to p46-61. Chimeric 
mice were immunized with p46-61/CFA in a hind foot- 
pad. After 9 d draining LNC were tested in a prohferation 
assay. The results from a group of four animals are pre- 
sented as mean A cpm + SEM. 
background  genes  as  B10.A(4R)  mice  raised  a  robust  re- 
sponse to p46-61. 
The  crux  of the  above  observations  is  that  B10.A(4R) 
mice have T  cells with TCk  that can interact eflaciently ei- 
ther with p46-59 or p48-61, in which extensions at one or 
the other end of the core determinant exist, but cannot in- 
teract  with  p46-61,  which  has  extensions  at  both  ends. 
Considering  the  fact that p46-61  can bind strongly to the 
A k molecule,  a logical conclusion from these results is that 
the presence of additional  amino acid residues at the NH  2 
and/or  the  COOH  terminus  in  p46-61  cause  steric  hin- 
drance in the interaction between TCR  of T  cells  reactive 
to the truncated peptides,  p46-59  or p48-61,  and the Ak/ 
p46-61 complex. In view of the long arginine side chains at 
positions  47  and  61,  we  tested  the  idea  that  they  were 
likely candidates for causing this hindrance.  Substitution of 
R61  either  by an  alanine  residue  or by L,  F,  N,  or K  in 
p46-61  renders  each of the variant peptides  immunogenic 
in  B10.A(4R)  mice.  Similarly,  p46-61(R47L)  (in  which 
R47 had been substituted with a leucine residue)  and p46- 
61(R47A) were also found to be immunogenic in B10.A(4R) 
mice.  (It is interesting  that in H-2  b mice,  we have shown 
that arginine-61  of HEL p46-61 prevents interaction of this 
peptide  with  the MHC  class  II molecule A b [37].)  In any 
event,  although B10.A(4R)  TCR  can manage to respond 
with a single hindering residue in place, but not both, they 
do  not possess  those  T  cells  that  are  unhindered  by R61 
and R47, whereas these T  cells  exist in CBA/J and B10.A 
mice as discussed below. 
Unresponsiveness to a Potential Detemfinant The  term "hindering  structures"  was first proposed by 
Brett et al.  (38)  to explain the lack of response to a deter- 
minant within equine myoglobin. In that study, it was sug- 
gested that a product of natural processing of equine myo- 
globin  probably had  hindering  structures  in  the  flanking 
residues of the determinant that interfere with presentation 
by I-A  k but not by the I-A  s molecule. A similar phenome- 
non of inhibition/stimulation ofT cell responses by amino 
acid residues either flanking the minimal determinant or at 
a  site  some distance  away from it,  has been described by 
other investigators  (39-43).  However, in the above-men- 
tioned  studies,  although  negative interference by flanking 
residues was assumed for the peptide interaction with Ia or 
TCR,  there  was  no  experimental demonstration  that  the 
synthetic peptide with its new extensions,  or the naturally 
processed determinant from the native antigen,  either was 
actually incapable of binding to the appropriate MHC mol- 
ecule (agretopic hindrance), or of interaction with the TCR 
(epitopic  hindrance).  To  the  best  of our knowledge,  we 
believe that our results represent the first complete experi- 
mental demonstration of the phenomenon of epitopic hin- 
drance.  Recently  we  have  found  that  an  HEL  disulfide 
peptide can bind to A k but fails to stimulate T  cells in the 
B10.A mouse and this may have a similar explanation (Ame- 
tani, A., and E. Sercarz, unpublished results).  This same type 
of finding had been given the same suggestive explanation 
earlier in  the  staphylococcal nuclease system by Liu et al. 
(42).  Some recent evidence favors the model that in class II 
MHC interactions, the unfolding antigen binds and is sub- 
sequently trimmed (44, 45). We postulate that steric epitopic 
hindrance will be a frequent occurrence during the process 
of  trimming  unfolded  protein  fragments.  The  dangling 
ends,  during  and even after trimming,  are likely to  affect 
the elicitation of the TCR repertoire, hindering full TCR 
access  to the MHC-Ag complex until the correct process  7 
ing step  occurs.  Sometimes,  as in  this  case,  a  rather small 
peptide such as ML p46-61  is left bound to MHC class II 
and retains hindering residues that can influence the access 
of T  cells,  either  during  positive  (activation)  or  negative 
(tolerance) interactions. 
We suggest that the  differential response of B10.A(4R) 
and CBA/J  (or B10.A)  mice to p46-61  is due  to a subtle 
difference  in  the  T  cell  repertoire  of these  strains.  The 
above three mouse strains share a subset of T  cells that are 
reactive to the truncated peptides, p46-59 and p48-61, but 
the interaction of the TCR on these cells with the p46-61/ 
A k complex is  hindered  by epitopic residues  within  p46- 
61. However, CBA/J and B10.A mice possess an additional 
subset of T  cells bearing TCR  that can accommodate the 
p46-61/A k  complex  and  efficiently  respond  to  it.  Since 
B10.A(4Ik) mice lack the E k molecule, and also have a re- 
combined  MHC  gene  segment  from  mice  of the  H-2  b 
haplotype,  we  suggest  that  the  responsiveness  of CBA/J 
and B10.A mice to p46-61, or the lack of it, in B10.A(4R) 
mice would  map within  the MHC  region  from near the 
class IIE  k gene rightward to the position of chromosomal 
recombination beyond the class I D  or L  regions or even 
slightly beyond the MHC into the class Ib region. Accord- 
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ingly, one or more peptides from a molecule coded for in 
this region such as E k (46)  or Dk/D  a could have positively 
selected a ML p46-61-responsive subset  of T  cells  in the 
CBA/J or B10.A strain which could not have been selected 
in  the  B10.A(4R)  strain.  The  T  cells  thus  positively se- 
lected may be the ones which are unhindered by R61  and 
R47 and are recruited by the A~/p46-61 complex in CBA/J 
and B10.A mice. The unresponsiveness of  B10.A(4R) mice 
to p46-61  could be explained by the absence of this partic- 
ular subset of T  cells.  In this relative sense, at best there is 
only  a  mini-hole  in  the  T  cell  repertoire  of B10.A(4R) 
mice.  Our results with bone marrow chimeric mice vali- 
date  the  above-mentioned  hypothesis.  Nevertheless,  we 
predicted that T  cells  available in the  T  cell repertoire of 
B10.A(4R)  mice could have raised a proliferative response 
to p46-61 even in the absence of this additional subset ofT 
cells described above for CBA/J and B10.A mice, provided 
there were no hindering residue(s) within this peptide. Our 
results  with  truncated  peptides  lacking  certain  NH2-  or 
COOH-terminal  residues  and  those  of the  R61/R47- 
substituted  peptides,  each  of which  is  immunogenic  in 
B10.A(4R)  mice,  provide  experimental  support  for  the 
above prediction. 
In this report we have described that p46-61  of ML pre- 
sented  by the  A k molecule  to  T  cells  from two  different 
strains of mice can give rise to entirely different outcomes: 
a proliferative T  cell response in the  case of CBA/J  mice 
but unresponsiveness in B10.A(4R)  mice, presumably due 
to a subtle difference in the T  cell repertoire of these two 
mouse strains.  It is alternatively possible that p46-61  does 
make  limited  contact  with  B10.A(4R)  TCR:  (a)  p46-61 
could induce a Thl response in CBA/J mice but a Th2 re- 
sponse in B10.A(4R)  mice. However, data from our pre- 
liminary studies do not support this alternative explanation. 
After immunization with p46-61  in a hind footpad and 9 d 
later, restimulation of draining LNC with p46-61  in vitro, 
T  cells  of CBA/J mice produced high amounts of IFN-% 
whereas those  from B10.A(4R)  produced very low levels 
of IFN-~ comparable to that by cells  cultured in medium 
without  antigen  (negative  control)  (data  not  shown).  In 
contrast, neither CBA/J nor B10.A(4R) cells produced IL-4 
in amounts above that produced by cells with medium alone. 
(b)  p46-61  of ML  could  behave  as  an  agonist  for  TCR 
from CBA/J mice but function like an antagonist (47)  for 
TCR from B10.A(4R)  mice. Thus, there could be differ- 
ential  signaling  by  the  same  MHC/peptide  ligand  after 
TCR-MHC/peptide interaction in the two mouse strains. 
In this regard, p46-59 and p48-61  could be categorized as 
agonists for both B10.A(4R)  and CBA/J mice.  (c) p46-61 
might be considered an altered peptide  ligand  (APL)  (48, 
49)  in  comparison to  the  truncated  peptides,  p46-59  and 
p48-61.  In this context, the truncated peptides elicit good 
proliferative  responses  in  B10.A(4R)  and  CBA/J  mice, 
whereas the APL, p46-61, induces a differential response in 
the  two  strains.  However,  since  the  core  determinant 
within p46-61 resides within residues 51-59, it is less likely 
that residues external to this core would create an APL. Ex- 
periments to define further the precise molecular aspects of TCR-Ak/p46-61 interaction in B10.A(4R.) and CBA/J (or 
B10.A) mice in view of the above two alternative possibili- 
ties (b and c) are currently in progress. 
Several cases are known where an antigenic determinant 
can  be  presented  and  the  appropriate  TCRs  are  present, 
but  no  T  cell  response  ensues  (19,  50--53).  This  immune 
"ignorance" should be distinguished from "true" self-toler- 
ance where the T  cells  are unable to respond, but has been 
mechanistically difficult to define.  Ignorance has been used 
in  referring  to  the  failure  of T  cell  interaction  with  the 
MHC-Ag  complex,  whereas  an  earlier  stage,  the  lack  of 
access  of certain  antigenic  determinants  to  MHC  mole- 
cules, fits under the term "crypticity" (54); in many senses, 
these  failures  of interaction  are  parallel.  Several  candidate 
mechanisms can be suggested:  (a) Actually, the  T  cells  are 
present but are not activated owing to a failure in costimu- 
lation necessary for their activation.  (b) The T  cells  are an- 
tagonized by related peptides  in the  local milieu.  (c)  Sup- 
pressive elements, either cells or molecules, exert a negative 
influence in the local milieu,  which however may be cir- 
cumvented elsewhere.  (d)  Lack of access of the  T  cells  to 
their  stimulus  occurs either because  of (0  sequestration  of 
the antigen or T  cells,  (i/) processing of antigen occurs but 
not its presentation because of insufficient MHC molecules 
available,  or  (ii  0  steric  hindrance:  a  physical  obstruction 
preventing  optimum  interaction  of the  T  cell  with  its 
ligand.  In this  work,  evidence has been gathered favoring 
mechanism (d-iii). 
It is now well-established that like foreign antigens,  self- 
antigens are also processed and presented by APCs (21, 55- 
57).  Furthermore,  the  display  of self-determinants  in  the 
thymus is a  critical factor in bringing about both negative 
and  positive  selection  (1,  4,  8,  58-61).  Previous  studies 
from our laboratory and others have shown that T  cells po- 
tentially  directed  against  cryptic  self-determinants  escape 
tolerance induction (21, 62-64).  We predict that there will 
be several determinants  from a variety of self-proteins that 
are processed efficiently by thymic APC and bind well  to 
MHC molecules, but are not presented efficiently to devel- 
oping T  cells due to the presence of hindering epitopic res- 
idues.  In this  situation,  in  the  negatively selecting  milieu, 
the interaction between the TCR and MHC/peptide com- 
plex would be very inefficient.  Consequently,  T  cells  po- 
tentially  directed  against  such self-determinants  would es- 
cape tolerance induction,  but perhaps become involved in 
positive selection  (58)  leading to enrichment  of the T  cell 
repertoire. The component of the T  cell repertoire described 
above would not pose a threat to the individual under nor- 
mal  circumstances.  However,  under conditions  leading  to 
aberrant  or upregulated antigen processing (65,  66),  a par- 
ticular determinant bearing a hindering residue may be pro- 
cessed differently so that the hindering residue is removed, 
resulting in efficient presentation  of the immunogenic self 
determinant  to ambient, autoreactive T  cells leading to in- 
duction ofautoimmunity. Often, as in the case of the CBA/J 
or the B10.A mouse, but not in the B10.A(4R.), a self-pep- 
tide in conjunction with self-MHC will positively select a 
TCR. repertoire member that is unhindered by R61 on ML 
p46-61: in such a case, a response will ensue.  Further in re- 
gard to autoimmunity, the susceptibility of the members of 
a  heterogeneous  population  to  an  autoimnmne  disease  is 
generally evaluated in the  context of the MHC  haplotype 
of the individuals  (67,  68).  However,  our results point  to 
the fact that although the MHC  might be capable of bind- 
ing  and  presenting  a  particular  pathogenic  autoantigenic 
determinant,  the composition of an individual's peripheral 
TCR  repertoire  can  clearly influence  susceptibility  to au- 
toimmunity. 
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